Literature DB >> 6269445

The myxoid tumors of somatic soft tissues.

D H Mackenzie.   

Abstract

Tumors and tumorous conditions of superficial and deep soft tissues may owe their naked-eye appearance and much of their bulk to the accumulation of mucopolysaccharide material or, on rare occasions, to edema. The so-called myxoid tumors may be chondroblastic, fibroblastic, lipoblastic, myoblastic, or neurogenic. Benign and malignant tumors may be encountered. Naked-eye and microscopic appearances are described. Pseudotumors such as bursae, ganglia, cutaneous mucinoses, fasciitis, and myxoid cysts may enter the differential diagnosis. The value of accurate documentation is stressed. Histochemistry can make a limited contribution to diagnosis. The entities described have been examined with regard to alcian blue staining with and without pretreatment with hyaluronidase. Alcian blue staining in the presence of increasing concentrations of magnesium chloride has been investigated and found to be of value in the identification of tumors of chondroblastic origin.

Entities:  

Mesh:

Year:  1981        PMID: 6269445     DOI: 10.1097/00000478-198107000-00004

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  7 in total

1.  Clinical appearance and pathological findings of conjunctival myxoma: Case report and literature review.

Authors:  Kuo-Hsuan Hung; Lung-Kun Yeh
Journal:  Am J Ophthalmol Case Rep       Date:  2020-08-05

Review 2.  Running GAGs: myxoid matrix in tumor pathology revisited: what's in it for the pathologist?

Authors:  Stefan M Willems; Malgorzata Wiweger; J Frans Graadt van Roggen; Pancras C W Hogendoorn
Journal:  Virchows Arch       Date:  2009-08-25       Impact factor: 4.064

3.  Magnetic resonance imaging of myxoid containing tumors.

Authors:  K K Peterson; D L Renfrew; R M Feddersen; J A Buckwalter; G Y el-Khoury
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

4.  Myxoid dermatofibroma on a great toe: a case report.

Authors:  Ahrim Moon; Nara Yoon; Hyun-Soo Kim
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

5.  STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.

Authors:  Vivek Subbiah; Caitlin McMahon; Shreyaskumar Patel; Ralph Zinner; Elvio G Silva; Julia A Elvin; Ishwaria M Subbiah; Chimela Ohaji; Dhakshina Moorthy Ganeshan; Deepa Anand; Charles F Levenback; Jenny Berry; Tim Brennan; Juliann Chmielecki; Zachary R Chalmers; John Mayfield; Vincent A Miller; Philip J Stephens; Jeffrey S Ross; Siraj M Ali
Journal:  J Hematol Oncol       Date:  2015-06-11       Impact factor: 17.388

6.  Texture analysis of magnetic resonance image to differentiate benign from malignant myxoid soft tissue tumors: A retrospective comparative study.

Authors:  Hyunsik Chang; Yusuhn Kang; Joong Mo Ahn; Eugene Lee; Joon Woo Lee; Heung Sik Kang
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.240

7.  Primary myxoid leiomyoma of the liver.

Authors:  Hee Seung Choi; Chang Won Jung; Soo Youn Cho; Sang Bum Kim; Sunhoo Park
Journal:  Korean J Pathol       Date:  2014-02-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.